May 11, 2018 / 11:35 AM / 2 months ago

BRIEF-Inmed Pharmaceuticals Reports Q3 Loss Per Share Of C$0.01

May 11 (Reuters) - InMed Pharmaceuticals Inc:

* INMED REPORTS THIRD QUARTER FISCAL 2018 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

* Q3 LOSS PER SHARE C$0.01

* INMED PHARMACEUTICALS - AT MARCH 31, 2018, CO’S CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS WERE $13.88 MILLION, VERSUS $6.71 MILLION AT JUNE 30, 2017 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below